Eugene Park

Mr. Park joined MEI Pharma in July 2021 with over 14 years of commercial experience in oncology within the biopharma industry, most recently as Vice President, Marketing at Coherus BioSciences. He has spent the last several years serving as the head of marketing for several small biotechnology companies, including Immunomedics and Halozyme Therapeutics, where he led efforts to build out the marketing organization and capabilities in preparation for the commercial launch of novel oncology therapeutics. Previously, Mr. Park spent 10 years in big pharma, moving through various sales and marketing roles and leading the multiple US launches at Pfizer Oncology and Novartis Oncology, His experience spans a broad range of tumor types and includes building brands for small molecule, biologic, and biosimilar assets. Mr. Park holds a BS in Biology from the Massachusetts Institute of Technology and an MBA from Columbia Business School.